ATE466076T1 - Gewebe transglutaminase - Google Patents

Gewebe transglutaminase

Info

Publication number
ATE466076T1
ATE466076T1 AT02710193T AT02710193T ATE466076T1 AT E466076 T1 ATE466076 T1 AT E466076T1 AT 02710193 T AT02710193 T AT 02710193T AT 02710193 T AT02710193 T AT 02710193T AT E466076 T1 ATE466076 T1 AT E466076T1
Authority
AT
Austria
Prior art keywords
tissue transglutaminase
ttg
conformaion
autoantibodies
epitopes
Prior art date
Application number
AT02710193T
Other languages
English (en)
Inventor
Michael Powell
Jadwiga Furmaniak
Bernard Smith
Original Assignee
Rsr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rsr Ltd filed Critical Rsr Ltd
Application granted granted Critical
Publication of ATE466076T1 publication Critical patent/ATE466076T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT02710193T 2001-02-07 2002-02-07 Gewebe transglutaminase ATE466076T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0103024.6A GB0103024D0 (en) 2001-02-07 2001-02-07 Assay for Autoantibodies to tissue transglutaminase
PCT/GB2002/000520 WO2002068616A2 (en) 2001-02-07 2002-02-07 Tissue transglutaminase

Publications (1)

Publication Number Publication Date
ATE466076T1 true ATE466076T1 (de) 2010-05-15

Family

ID=9908287

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02710193T ATE466076T1 (de) 2001-02-07 2002-02-07 Gewebe transglutaminase

Country Status (6)

Country Link
US (1) US20050221302A1 (de)
EP (1) EP1360280B1 (de)
AT (1) ATE466076T1 (de)
DE (1) DE60236143D1 (de)
GB (1) GB0103024D0 (de)
WO (1) WO2002068616A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1978364B1 (de) * 2007-04-06 2011-06-01 Zedira GmbH Transglutaminase 6 als diagnostischer Indikator für Autoimmunerkrankungen
GB201209096D0 (en) 2012-05-24 2012-07-04 Medical Res Council Technology Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012529A1 (en) * 1992-12-03 1994-06-09 The Regents Of The University Of California Improved reagents and methods for the diagnosis and treatment of diabetes and stiff man syndrome
DE19630557C2 (de) * 1996-07-18 1998-07-02 Schuppan Detlef Priv Doz Dr Dr Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie

Also Published As

Publication number Publication date
WO2002068616A3 (en) 2003-03-13
WO2002068616A2 (en) 2002-09-06
US20050221302A1 (en) 2005-10-06
EP1360280A2 (de) 2003-11-12
GB0103024D0 (en) 2001-03-21
DE60236143D1 (de) 2010-06-10
EP1360280B1 (de) 2010-04-28
WO2002068616A8 (en) 2004-02-12

Similar Documents

Publication Publication Date Title
FR10C0025I2 (fr) Protéines de fusion du récepteur de IL-1 utilisées comme antagonistes et méthodes d'utilisation et de fabrication
DK1606318T3 (da) Forbedrede Fc-fusionsproteiner
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
WO2003014325A3 (en) Protein design automation for protein libraries
ATE464374T1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
ATE353955T1 (de) Durch zelloberflächenmoleküle induzierte makrophagenaktivierung
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
NO20014131D0 (no) Epitoper eller mimotoper avledet fra C-epsilon-3- eller C- epsilon-4-domener fra IgE, antagonister derav og deresterapeutiske anvendelser
DE60226852D1 (de) Lentivirale verpackungskonstrukte
WO2002030959A3 (en) Peptides derived from smac (diablo) and methods of use therefor
IL145689A0 (en) Methods
ATE513040T1 (de) Zinkfingerdomänenbibliotheken
BR9713668A (pt) Agonistas de receptores hematopoiéticos quiméricos multifuncionais
DK1145012T3 (da) Fremgangsmåder og kits til sekventering af polypeptider
AU2002365269A8 (en) Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses
DE60236143D1 (de) Gewebe transglutaminase
DE602004030824D1 (de) An der oberfläche befindliche campylobacter jejuni-polypeptide
DE60217079D1 (de) Nachweis und quantifizierung von cripto-1
EA200400392A1 (ru) Связывающий каспазу-8 белок, его получение и применение
WO2002055536A3 (en) Regulation of target protein activity through modifier proteins
ATE240349T1 (de) Peptide zur inhibierung von hpv e6-proteinen
WO2002027327A3 (en) Rapid profiling of the interactions between a chemical entity and proteins in a given proteome
SE0301936D0 (sv) New polypeptide
ATE307201T1 (de) Srcr domäne-enthaltendes protein
AU2003260546A8 (en) Device for the presentation of peptides or proteins, method for the preparation and use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties